Cargando…

Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients

BACKGROUND: Minimally important differences (MIDs) allow interpretation of the clinical relevance of health-related quality of life (HRQOL) results. This study aimed to estimate MIDs for all European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dirven, Linda, Musoro, Jammbe Z, Coens, Corneel, Reijneveld, Jaap C, Taphoorn, Martin J B, Boele, Florien W, Groenvold, Mogens, van den Bent, Martin J, Stupp, Roger, Velikova, Galina, Cocks, Kim, Sprangers, Mirjam A G, King, Madeleine T, Flechtner, Hans-Henning, Bottomley, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328025/ https://www.ncbi.nlm.nih.gov/pubmed/33598685 http://dx.doi.org/10.1093/neuonc/noab037

Ejemplares similares

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
por: Gamper, Eva M., et al.
Publicado: (2021)

Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
por: Musoro, Jammbe Z, et al.
Publicado: (2019)

Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
por: Musoro, Zebedee Jammbe, et al.
Publicado: (2018)

Comparing higher order models for the EORTC QLQ-C30
por: Gundy, Chad M., et al.
Publicado: (2011)

Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients
por: Dirven, Linda, et al.
Publicado: (2017)

Investigating the response scale of the EORTC QLQ-C30 in German cancer patients and a population survey
por: Koller, Michael, et al.
Publicado: (2021)

Is the EORTC QLQ‐C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
por: Oort, Quirien, et al.
Publicado: (2022)

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
por: Coon, Cheryl D., et al.
Publicado: (2022)

Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile
por: Rojas-Concha, Leslye, et al.
Publicado: (2020)

Correction to: Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile
por: Rojas-Concha, Leslye, et al.
Publicado: (2020)

Development and psychometric evaluation of item banks for memory and attention – supplements to the EORTC CAT Core instrument
por: Rogge, AA, et al.
Publicado: (2023)

Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I–III
por: Oort, Quirien, et al.
Publicado: (2021)

Psychometric properties of the EORTC QLQ-C30 in Uganda
por: Naamala, Allen, et al.
Publicado: (2021)

Assessing measurement invariance in the EORTC QLQ-C30
por: van Roij, Janneke, et al.
Publicado: (2021)

A Multinational Pilot Study on Patients’ Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
por: van Leeuwaarde, Rachel S., et al.
Publicado: (2022)

Reliability and Validity of the Arabic Version of the EORTC QLQ-C30 and QLQ-BR23 Questionnaires
por: Jassim, Ghufran, et al.
Publicado: (2020)

Equivalence testing of a newly developed interviewer-led telephone script for the EORTC QLQ-C30
por: Piccinin, Claire, et al.
Publicado: (2021)

Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
por: Holzner, Bernhard, et al.
Publicado: (2012)

Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess Health-related quality of life in patients with colorectal cancer
por: Thaysen, Henriette Vind, et al.
Publicado: (2012)

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
por: Khoshnevisan, Alireza, et al.
Publicado: (2012)

Measuring health-related quality of life in colorectal cancer patients: systematic review of measurement properties of the EORTC QLQ-CR29
por: van der Hout, Anja, et al.
Publicado: (2019)

Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients
por: Sully, Kate, et al.
Publicado: (2019)

Health-related Quality of Life in Croatian General Population and Multiple Myeloma Patients Assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 Questionnaires
por: Ficko, Sanja Ledinski, et al.
Publicado: (2019)

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
por: Ediebah, D E, et al.
Publicado: (2014)

Impact of neurocognitive deficits on patient–proxy agreement regarding health-related quality of life in low-grade glioma patients
por: Ediebah, Divine E., et al.
Publicado: (2016)

Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG Studies
por: Sleurs, Charlotte, et al.
Publicado: (2021)

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period
por: Coomans, Marijke B, et al.
Publicado: (2022)

Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
por: Proskorovsky, Irina, et al.
Publicado: (2014)

Associations between the spiritual well-being (EORTC QLQ-SWB32) and quality of life (EORTC QLQ-C30) of patients receiving palliative care for cancer in Cyprus
por: Kyranou, Maria, et al.
Publicado: (2021)

Translation and Validation of the Sinhala Version of the EORTC-QLQ-CR29 Questionnaire
por: Wickramasinghe, Dakshitha P, et al.
Publicado: (2020)

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
por: Coomans, Marijke B, et al.
Publicado: (2019)

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients
por: Coomans, Marijke B, et al.
Publicado: (2020)

The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study
por: Mauer, M, et al.
Publicado: (2007)

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling
por: Coomans, Marijke B, et al.
Publicado: (2020)

Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
por: Uwer, Lionel, et al.
Publicado: (2011)

Quality of life of patients after retropubic prostatectomy - Pre- and postoperative scores of the EORTC QLQ-C30 and QLQ-PR25
por: Bach, Peter, et al.
Publicado: (2011)

Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore
por: Tan, May Leng, et al.
Publicado: (2014)

Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer
por: Lin, Jin-Bo, et al.
Publicado: (2017)

Normative data for the EORTC QLQ-C30 from the Austrian general population
por: Lehmann, Jens, et al.
Publicado: (2020)

Korean Translation and Psychometric Evaluation of Korean Version EORTC QLQ-BRECON23
por: Bok, Soo-Kyung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_908cge6c275thmj7dc70044b4b